AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6146861 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide 80 mg/m2 on days 1‐14, intravenous methotrexate 32 mg/m2 on days 1 and 8, and intravenous fluorouracil 480 mg/m2 on days 1 and 8 (CMF), repeated every 28 days for twelve cycles.
Number of subjects: 327
Study 6146861 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF treatment
Number of subjects: 327
Study 6146861 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 327
Study 31799940 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Decision Aid
Number of subjects: 120
Study 31799940 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 120
Study 28364419 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil treatment during abstinence
Number of subjects: 43
Study 27185725 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 μg/kg IV infusion
Number of subjects: 90
Study 27185725 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol 0.25 mg/kg IV
Number of subjects: 90
Study 27185725 — intervention group
Group type: COMPARATOR
Intervention: Saline 10 mL IV
Number of subjects: 90
Study 24376009 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe obesity
Number of subjects: 0
Study 24376009 — intervention group
Group type: COMPARATOR
Intervention: Moderate obesity
Number of subjects: 0
Study 21971575 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 70 mg orally, once weekly
Number of subjects: 90
Study 21971575 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 40 mg orally once daily
Number of subjects: 90
Study 19540138 — intervention group
Group type: EXPERIMENTAL
Intervention: General anaesthesia (GA)
Number of subjects: 27
Study 19540138 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthesia (LA)
Number of subjects: 27
Study 17556722 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic heparin
Number of subjects: 1994
Study 17556722 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1994
Study 14672887 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Therapy (OT)
Number of subjects: 326
Study 14672887 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study 11137832 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 13
Study 11137832 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (200 mg/day)
Number of subjects: 13
Study 9439404 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 50
Study 9439404 — intervention group
Group type: COMPARATOR
Intervention: 1.5% glycine
Number of subjects: 50
Study 8339624 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (10 mg/kg)
Number of subjects: 30
Study 8339624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 3789327 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline slow-release tablets (Bricanyl Depot), 5 mg twice daily
Number of subjects: 10
Study 3789327 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline ordinary tablets (Bricanyl), 2.5 mg three times daily
Number of subjects: 10
Study 31469776 — intervention group
Group type: EXPERIMENTAL
Intervention: AS04-adjuvanted HPV-16/18 vaccine (2-dose schedule)
Number of subjects: 74
Study 28912305 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/day)
Number of subjects: 62
Study 28912305 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle counseling
Number of subjects: 62
Study 26907917 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive-scattering proton therapy (PT)
Number of subjects: 20
Study 26907917 — intervention group
Group type: COMPARATOR
Intervention: Intensity modulated radiation therapy (IMRT)
Number of subjects: 20
Study 24519012 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8 g/kg of alcohol
Number of subjects: 30
Study 24519012 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 g/kg)
Number of subjects: 30
Study 23000125 — intervention group
Group type: EXPERIMENTAL
Intervention: LAIV
Number of subjects: 0
Study 23000125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19393843 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP infusion (0.4 microg/kg/h) + BUP boluses (0.15 microg/kg)
Number of subjects: 120
Study 19393843 — intervention group
Group type: EXPERIMENTAL
Intervention: MO infusion (10 microg/kg/h) + MO boluses (5 microg/kg)
Number of subjects: 120
Study 19393843 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP infusion (0.4 microg/kg/h) + MO boluses (5 microg/kg)
Number of subjects: 120
Study 19393843 — intervention group
Group type: EXPERIMENTAL
Intervention: MO infusion (10 microg/kg/h) + BUP boluses (0.15 microg/kg)
Number of subjects: 120
Study 17613395 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (ERL)
Number of subjects: 34
Study 17613395 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 34
Study 15135473 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) biopsy using Patent blue V and 99mTc-radiolabelled colloidal albumin
Number of subjects: 9
Study 15135473 — intervention group
Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 9
Study 11818011 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive total hemoglobin measurement using a five-wavelength light emitting diode array
Number of subjects: 129
Study 9882760 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg p.o.)
Number of subjects: 20
Study 9882760 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (20 mg p.o.)
Number of subjects: 20
Study 9882760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7721974 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg nitroglycerin (LDG)
Number of subjects: 20
Study 7721974 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg nitroglycerin (HDG)
Number of subjects: 20
Study 7721974 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study 2199853 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopiroxolamine globules, 100 mg nightly for six days
Number of subjects: 46
Study 2199853 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole vaginal tablets, 200 mg nightly for six days
Number of subjects: 46
Study 7014121 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propranolol, 40 mg
Number of subjects: 13
Study 7014121 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 13
Study 31036037 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary education and usual care
Number of subjects: 20
Study 31036037 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 28431191 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cycled light (ECL) starting at 28 weeks postmenstrual age (PMA)
Number of subjects: 118
Study 28431191 — intervention group
Group type: COMPARATOR
Intervention: Late cycled light (LCL) starting at 36 weeks PMA
Number of subjects: 118
Study 28431191 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cycled light (ECL)
Number of subjects: 118
Study 28431191 — intervention group
Group type: COMPARATOR
Intervention: Late cycled light (LCL)
Number of subjects: 118
Study 25212414 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA training at the beginning of job placement
Number of subjects: 50
Study 25212414 — intervention group
Group type: COMPARATOR
Intervention: PDA training after 12 weeks without PDA support
Number of subjects: 50
Study 25212414 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups using a PDA
Number of subjects: 50
Study 24220165 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice fortified with iron (Ultrarice®)
Number of subjects: 171
Study 24220165 — intervention group
Group type: COMPARATOR
Intervention: Standard household rice (control)
Number of subjects: 171
Study 21608223 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood activating and stasis removing herbs
Number of subjects: 141
Study 21608223 — intervention group
Group type: COMPARATOR
Intervention: Blood cooling and arresting herbs
Number of subjects: 141
Study 19910803 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training program (at least 10 minutes per day, 3 days per week, for 4 weeks)
Number of subjects: 0
Study 19910803 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training program
Number of subjects: 0
Study 19910803 — intervention group
Group type: EXPERIMENTAL
Intervention: Various methods of balance training (including tilt boards, unstable surfaces, and dynamic body movements)
Number of subjects: 0
Study 17432396 — intervention group
Group type: EXPERIMENTAL
Intervention: Restored teeth with Syntac Single adhesive and Tetric Ceram composite under 150 N load
Number of subjects: 20
Study 17432396 — intervention group
Group type: EXPERIMENTAL
Intervention: Restored teeth with Syntac Single adhesive and Tetric Ceram composite
Number of subjects: 20
Study 17432396 — intervention group
Group type: COMPARATOR
Intervention: Unaltered teeth under 150 N load
Number of subjects: 20
Study 17432396 — intervention group
Group type: COMPARATOR
Intervention: Unaltered teeth (baseline condition)
Number of subjects: 20
Study 12772743 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone hydrogel lenses (Focus NIGHT & DAY, Focus DAILIES)
Number of subjects: 39
Study 12772743 — intervention group
Group type: COMPARATOR
Intervention: Conventional hydrogels (ACUVUE 2, Proclear Compatibles)
Number of subjects: 39
Study 12772743 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic group
Number of subjects: 39
Study 11006450 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftibuten 9 mg/kg/day for 5 days
Number of subjects: 180
Study 11006450 — intervention group
Group type: COMPARATOR
Intervention: Ceftibuten 9 mg/kg/day for 10 days
Number of subjects: 180
Study 8839497 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal-based precooked porridge offered twice daily for 3 months (558-790 kJ/d)
Number of subjects: 447
Study 8839497 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 447
Study 1427411 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum progesterone (P) levels in ectopic pregnancy (EP)
Number of subjects: 0
Study 1427411 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-hydroxyprogesterone (17-OHP) levels in ectopic pregnancy (EP)
Number of subjects: 0
Study 1427411 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum progesterone (P) levels in intrauterine pregnancies (IUP)
Number of subjects: 0
Study 6436891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 6436891 — intervention group
Group type: EXPERIMENTAL
Intervention: 195 mg caffeine
Number of subjects: 24
Study 6436891 — intervention group
Group type: EXPERIMENTAL
Intervention: 325 mg caffeine
Number of subjects: 24
Study 3555083 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 IU of oxytocin in 10 ml of sodium chloride into the umbilical vein
Number of subjects: 51
Study 3555083 — intervention group
Group type: COMPARATOR
Intervention: 10 ml of sodium chloride
Number of subjects: 51
Study 3555083 — intervention group
Group type: COMPARATOR
Intervention: Manual removal of the placenta
Number of subjects: 51
Study 29246417 — intervention group
Group type: EXPERIMENTAL
Intervention: Incision and Drainage (I&D) with drain placement
Number of subjects: 81
Study 29246417 — intervention group
Group type: COMPARATOR
Intervention: Mock I&D procedure with mock drain placement
Number of subjects: 81
Study 26724798 — intervention group
Group type: EXPERIMENTAL
Intervention: CryotopSC device
Number of subjects: 48
Study 26724798 — intervention group
Group type: COMPARATOR
Intervention: CBSvit device
Number of subjects: 48
Study 24048623 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised reading and exploration training (35 hours)
Number of subjects: 70
Study 24048623 — intervention group
Group type: COMPARATOR
Intervention: Control training (35 hours)
Number of subjects: 70
Study 23412078 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 20
Study 23412078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20138301 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide + surfactant (every 8 hours)
Number of subjects: 67
Study 20138301 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide + surfactant
Number of subjects: 67
Study 20138301 — intervention group
Group type: COMPARATOR
Intervention: Control (surfactant only)
Number of subjects: 67
Study 18407876 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 11
Study 18407876 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 11
Study 17081363 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (n = 24)
Number of subjects: 49
Study 17081363 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (Control, n = 25)
Number of subjects: 49
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy with antiepileptic drugs (AEDs)
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring for dosage tailoring
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer antiepileptic agents
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine and treatment guidelines
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-tailored AED selection and dose individualization
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy in refractory epilepsies
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel antiepileptic drugs
Number of subjects: 0
Study 12823568 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploration of new targets for prevention of epileptogenesis
Number of subjects: 0
Study 10917409 — intervention group
Group type: EXPERIMENTAL
Intervention: R(+)‐nicotine
Number of subjects: 30
Study 10917409 — intervention group
Group type: EXPERIMENTAL
Intervention: S(‐)‐nicotine
Number of subjects: 30
Study 10917409 — intervention group
Group type: COMPARATOR
Intervention: S(‐)‐nicotine at trigeminal concentrations
Number of subjects: 30
Study 9151592 — intervention group
Group type: EXPERIMENTAL
Intervention: e-PTFE membrane with biomaterial (DFDBA or Bio Oss)
Number of subjects: 12
Study 9151592 — intervention group
Group type: COMPARATOR
Intervention: e-PTFE membrane without biomaterial
Number of subjects: 12
Study 1430302 — intervention group
Group type: EXPERIMENTAL
Intervention: Encainide with food
Number of subjects: 14
Study 1430302 — intervention group
Group type: COMPARATOR
Intervention: Encainide after fasting
Number of subjects: 14
Study 1430302 — intervention group
Group type: EXPERIMENTAL
Intervention: Food effect on O-demethyl-encainide (ODE)
Number of subjects: 14
Study 1430302 — intervention group
Group type: EXPERIMENTAL
Intervention: Food effect on methoxy-O-demethyl-encainide (MODE)
Number of subjects: 14
Study 1430302 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electrocardiogram 2 hours after dose administration
Number of subjects: 14
Study 3973042 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructions to report distress and personal problems (Study 1)
Number of subjects: 142
Study 3973042 — intervention group
Group type: EXPERIMENTAL
Intervention: R-S scale scores (Study 2)
Number of subjects: 142
Study 30638262 — intervention group
Group type: EXPERIMENTAL
Intervention: ProRoot MTA
Number of subjects: 69
Study 30638262 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 69
Study 29556707 — intervention group
Group type: EXPERIMENTAL
Intervention: Hammock-shaped mini-sling
Number of subjects: 126
Study 29556707 — intervention group
Group type: COMPARATOR
Intervention: U-shaped mini-sling
Number of subjects: 126
Study 27329780 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical natamycin
Number of subjects: 323
Study 27329780 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical voriconazole
Number of subjects: 323
Study 27329780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with antifungal agents
Number of subjects: 323
Study 25010608 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-dose albendazole
Number of subjects: 0
Study 25010608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25010608 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichuris trichiura-infected children
Number of subjects: 0
Study 25010608 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with low-intensity T. trichiura and hookworm infections
Number of subjects: 0
Study 25010608 — intervention group
Group type: EXPERIMENTAL
Intervention: Children infected with hookworm and Ascaris lumbricoides
Number of subjects: 0
Study 22202581 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-cell melanoma vaccine (Canvaxin) plus Bacille Calmette-Guerin (BCG)
Number of subjects: 244
Study 22202581 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Bacille Calmette-Guerin (BCG)
Number of subjects: 244
Study 20860537 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra water intake (EWI, an additional 30 ml water/kg body weight per day)
Number of subjects: 20
Study 20860537 — intervention group
Group type: COMPARATOR
Intervention: Regular water intake (RWI)
Number of subjects: 20
Study 20860537 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra water intake (EWI)
Number of subjects: 20
Study 17905800 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 65
Study 17905800 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 65
Study 15681320 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced volumetric MRI
Number of subjects: 0
Study 15681320 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 0
Study 12525733 — intervention group
Group type: EXPERIMENTAL
Intervention: ALS subjects
Number of subjects: 25
Study 10891628 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine 12.5 mg
Number of subjects: 8
Study 10891628 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine 25 mg
Number of subjects: 8
Study 10891628 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine 50 mg
Number of subjects: 8
Study 10891628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10891628 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 8
Study 8752234 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (0.6 mg plus 30 micrograms/minute)
Number of subjects: 302
Study 8752234 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (6.5 mg bolus plus 300 micrograms/minute)
Number of subjects: 302
Study 8752234 — intervention group
Group type: COMPARATOR
Intervention: Ritodrine
Number of subjects: 302
Study 8752234 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (other regimens)
Number of subjects: 302
Study 8752234 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (overall)
Number of subjects: 302
Study 1362394 — intervention group
Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 475
Study 1362394 — intervention group
Group type: EXPERIMENTAL
Intervention: dopamine agonists
Number of subjects: 475
Study 1362394 — intervention group
Group type: EXPERIMENTAL
Intervention: l-deprenyl
Number of subjects: 475
Study 3891617 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg oral)
Number of subjects: 14
Study 3891617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31427349 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture for chronic neck pain
Number of subjects: 0
Study 31427349 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 29495529 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 0
Study 29495529 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 27167210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP at 10 cm H2O
Number of subjects: 26
Study 27167210 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP at 1.5 cm H2O
Number of subjects: 26
Study 27167210 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no CPAP)
Number of subjects: 26
Study 24127698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) program
Number of subjects: 0
Study 24127698 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 0
Study 22397811 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-salt label
Number of subjects: 50
Study 22397811 — intervention group
Group type: COMPARATOR
Intervention: No health label
Number of subjects: 50
Study 22397811 — intervention group
Group type: COMPARATOR
Intervention: Heart Foundation Tick
Number of subjects: 50
Study 22397811 — intervention group
Group type: EXPERIMENTAL
Intervention: Soups with 15% less sodium
Number of subjects: 50
Study 22397811 — intervention group
Group type: EXPERIMENTAL
Intervention: Soups with 30% less sodium
Number of subjects: 50
Study 22397811 — intervention group
Group type: COMPARATOR
Intervention: Soups without health labels
Number of subjects: 50
Study 20350164 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional-dose IPV (0.1 mL, or 1/5 of a full dose) given intradermally
Number of subjects: 471
Study 20350164 — intervention group
Group type: COMPARATOR
Intervention: Full-dose IPV given intramuscularly
Number of subjects: 471
Study 20350164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 471
Study 18714060 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-coated endotracheal tube
Number of subjects: 2003
Study 18714060 — intervention group
Group type: COMPARATOR
Intervention: Uncoated endotracheal tube
Number of subjects: 2003
Study 15939850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 18
Study 15939850 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometry (IS)
Number of subjects: 18
Study 12709724 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefditoren pivoxil 200 mg twice daily for 10 days
Number of subjects: 30